Sanofi reduces US insulin prices for the uninsured

On Friday, French pharmaceutical firm Sanofi reduced its insulin price for uninsured patients in the US significantly. This comes as the Affordable Insulin Now Act has passed the House of Representatives, and a bi-partisan bill to cap costs is being introduced to the Senate.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
US Senators introduce bill to cap insulin prices
For subscribers